{
  "image_filename": "figure_p1_det_0_003.png",
  "image_path": "CDC_Influenza_vaccines/extracted/figures/figure_p1_det_0_003.png",
  "image_type": "Figure",
  "page_number": 1,
  "block_id": "det_0_003",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "Table listing 2023\u201324 US influenza vaccines by trade name (manufacturer), presentations, age indications, HA content per dose, administration route, and thimerosal content. Includes IIV4 egg-based vaccines (Afluria Quadrivalent, Fluarix Quadrivalent, FluLaval Quadrivalent, Fluzone Quadrivalent), cell culture\u2013based cCIV4, and high-dose IIV4. The table does not mention Flublok (quadrivalent) or any evaluation against Fluarix; it only lists vaccine formulations and dosing details, so it does not support the claim Note: Image appears to be a product listing table without clinical trial comparisons",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Table listing 2023\u201324 US influenza vaccines by trade name (manufacturer), presentations, age indications, HA content per dose, administration route, and thimerosal content. Includes IIV4 egg-based vaccines (Afluria Quadrivalent, Fluarix Quadrivalent, FluLaval Quadrivalent, Fluzone Quadrivalent), cell culture\u2013based cCIV4, and high-dose IIV4.",
    "evidence_found": null,
    "reasoning": "The table does not mention Flublok (quadrivalent) or any evaluation against Fluarix; it only lists vaccine formulations and dosing details, so it does not support the claim",
    "confidence_notes": "Image appears to be a product listing table without clinical trial comparisons"
  }
}